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Medicare reimbursement rates across the United States have varied by as much as 49-130% 
across healthcare facilities.  Geographic adjustments and severity of medical diagnoses attribute 
to some dissimilarity; however, the source of longer hospitalization and higher re-admission 
rates among Medicare patients requires financial consistency.  The research encompassed (N = 
3000) patients with hypertension as the focus for the study because this is a critical group of 
Medicare patients with a chronic disease that has been identified as a silent killer.  The principal 
goal that drove this research study was to explain the variations in length of stay for Medicare 
patients with hypertension.  The theoretical framework was the epidemiological triad model 
composed of person, place, and time variables.   A secondary data set was acquired from the 
Healthcare Cost and Utilization Project Nationwide database of the National Inpatient Sample 
for the duration of 2011 - 2013.  A multiple logistic regression analysis was conducted to 
determine if there was a correlation between length of stay and reimbursement rates for 
hypertensive Medicare patients.  The findings of this research study provided an analytical 
explanation for the forces that have been driving Medicare patients’ LOS, and rate of 
reimbursement.  The research study yielded variations in the rate of reimbursement for a 
government entity in medical charges by illustrating the utilization of geographic price 
variations.  The findings revealed that the categorical variable LOS and reimbursement rates for 
Medicare hypertensive patients had a significant correlation, and with higher reimbursement 
rates that were associated with longer hospital duration.  The findings of the research study may 
inform Medicare decision-makers to eliminate geographic price variation and provide greater 
consistency in the rate of reimbursement, as well as a uniformity in length of stay across all 
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Section 1:  Introduction of the Study 
Introduction 
Medicare reimbursement rates are primarily regulated by the federal government and 
receive further itemization per state.  Respectively each Medicare reimbursement claim 
undergoes a lengthy process prior to reimbursement of claims being compensated.  This process 
entails the coordination of benefits, coverage implication, billing, coding, denials, audits, and 
appeals.  Additionally, each itemized claim requires comprehensive detailed information per 
patient and specific services rendered during the date(s) of service from the provider (Centers for 
Medicare & Medicaid Services, 2017).  Medicare reimbursement differs by state and is impacted 
by the classification of reimbursement rate.  Medicare reimbursement is comprised of eight 
categorical rates that assist in medical coverage.  These rates entail medical assistance, capitated, 
critical access hospitals, federally qualified health centers, fee-for-services, Indian health service, 
managed care organization, and Medicare waiver rates (Centers for Medicare & Medicaid 
Services, 2017).  An additional factor that contributes to Medicare reimbursement rate involves 
geographic adjustments that are based on locality within rural regions of the United States, which 
interpose a 5% to 10% increase above the national average (Centers for Medicare & Medicaid 
Services, 2017).   
The rate of Medicare reimbursement must adhere to federally legislated guidelines 
despite variations among states to ensure corroborated payment parameters.  These parameters 
also dictate the payment rate for length of stay (LOS) per inpatient hospitalization or encounter 
(Weiss & Elixhauser, 2012).  Medicare Part A is the segment of Medicare that insures a patient’s 
LOS for specific healthcare facilities such as acute care, critical access, inpatient rehabilitation, 
and long-term care hospitals (Medicare.gov, 2017).  From 2008 to 2012 the hospital inpatient 





usage by Medicare patients (Weiss & Elixhauser, 2012).  The LOS for Medicare recipients 
decreased 1.9%between 2008 and 2012, whereas the cost gradually increased 0.7% over the 
duration of 4 years.  For Medicare recipients (65 years and older), the rate of hospitalization has 
decreased nearly 4% for 4 consecutive years during the timeframe of 2008 to 2012 (Weiss & 
Elixhauser, 2012).    
Hypertension and the rate of Medicare reimbursement for the LOS have exhibited 
variation from 2003 to 2012 with a decline in usage beginning in 2008 (Weiss & Elixhauser, 
2012).   In 2008 hypertension among Medicare patients was the most common comorbidity 
accounting for 69% of the hospitalizations across the United States (Fraze, Jiang & Burgess, 
2010).  The average hospitalization cost per hypertensive Medicare patient annually was 
$30,286, with an average LOS of 11 days in 2013; however, the average LOS for non-
governmental applied insurance had a higher average LOS of 28.5 days for the same timeframe 
(Canavan, 2013).  Medicare inpatient utilization management undergoes a process of applying 
relative diagnosis related groups (DRGs) to further establish the necessity of hypertensive 
Medicare patients LOS.  The inpatient utilization management process may be a determining 
factor in variations among Medicare beneficiaries and private insurance holders.  The utilization 
practice attempted to explain the stringent guidelines that healthcare organizations must adhere 
to in applying DRG’s to re-admissions for hypertensive Medicare patients (Weiss & Elixhauser, 
2012).    
Variations among reimbursement rates for hypertensive Medicare beneficiaries and LOS 
were expected to differ by state; however, establishing further understanding of the variation 
within insurance providers required in depth exploration.  Inpatient utilization of hypertensive 





variation nearly $30,000 annually (Burke, Hunsche, Régulier, Nagao, Buzinec, & Drake, 2015).  
In the research study, comparisons of variables utilized a multivariate analysis to assist in 
determining elements associated with the LOS during hypertensive patient hospitalization 
(American Psychological Association, 2012). A multivariate regression model assisted in 
determining predictors in LOS, the relevance for Medicare reimbursement rates, and further 
explained variations (Qureshi, et al, 2013).  The analysis also attempted to assist in stabilizing 
the pre-determined LOS for Medicare recipients. 
              Problem Statement 
The source of longer lengths of hospital stay and extended hospitalization among 
Medicare patients have not been fully understood.  Patients with hypertension were chosen as the 
focus for the study because this is a critical group of Medicare patients, and the logic of their 
lengths of hospital stay, though previously explored, was not completely understood 
(Medicaid.gov, 2016; Qureshi et al, 2013).  The LOS for Medicare recipients were partially 
predetermined by the rate of reimbursement as it pertained to each state.  Due to variations 
among states, there was no established rate of reimbursement per encounter for Medicare 
patients (Cabin, Himmelstein, Siman & Woolhandler, 2014).   
Some elements assisted in determining the rate of reimbursement per occurrence.  These 
included the medical condition (e.g., hypertension), the managed care organization’s 
reimbursement rate, the fee-for-service rate, and Medicaid/Medicare waiver rates.  Additional 
factors that partially determined the LOS for Medicare patients included supplemental private 
health, insurance, the state in which the hospital care was delivered, and the year in which the 
patient was hospitalized (Medicaid.gov, 2016).  These factors regulate the government outlier 





(Freitas, Silva-Costa, Lopes, Garcia-Lema, Teixeira-Pinto, Brazdil & Costa-Pereira, 2012). 
Governmental regulations that determine reimbursement rates and LOS continue to vary 
considerably and create variations depending on location, current reform, and organizational 
dynamics (Kim, Kleerup, Ganz, Ponce, Lorenz & Needleman, 2015; Medicaid.gov, 2016). 
Purpose of the Study 
The principal goal that drove the research study was to explain the variations in LOS for 
Medicare patients with hypertension (O'Brien, Xue, Ingersoll & Kelly, 2013).  The knowledge 
gap targeted by this study involved the mix of reimbursement rates that shortened lengths of stay, 
thus containing costs for Medicare patients.  Doing so required adjusting for the effects of 
covariates.  These included a common medical comorbidity (diabetes), gender, race or ethnicity, 
year, and the region in which the care was provided (Cabin et al, 2014). 
Research Questions and Hypotheses 
RQ1:    Are reimbursement rates related to the LOS for Medicare patients with                 
hypertension as the reason for admission after controlling for geographic region, age, year, 
gender race/ethnicity, and diabetes? 
H1: The hospital reimbursement rate is related to the LOS for Medicare patients with 
hypertension as the reason for admission when controlling for geographic region, age, year, 
gender, race/ethnicity, and diabetes. 
H2:  The hospital reimbursement rate is not related to the LOS for Medicare patients with 
hypertension as the reason for admission when controlling for geographic region, age, year, 
gender, race/ethnicity, and diabetes. 
RQ2:    Are the hospital reimbursement rates associated with prolonged hospitalization               
for Medicare patients admitted for hypertension when controlling for geographic region, age, 





H3:  The hospital reimbursement rate is associated with prolonged hospitalization for Medicare 
patients with hypertension as the reason for admission when controlling for geographic region, 
age, year, gender, race/ethnicity, and diabetes. 
H4:  The hospital reimbursement rate is not associated with prolonged hospitalization for 
Medicare patients with hypertension as the reason for admission when controlling for geographic 
region, age, year, gender, race/ethnicity, and diabetes. 
Theoretical Framework 
The theoretical framework for the research study was the epidemiological triad model 
(Rohrer, Grover & Moats, 2013).  The triad was composed of person, place, and time variables. 
The triad model has been used in epidemiological investigation of disease outbreaks and has 
been applied to hospital outcomes.  This particular conceptual framework guided an 
epidemiological exploration of variations in LOS and its association with triad variables (Centers 
for Disease Control and Prevention.gov, 2017).  The epidemiological triad model has been 
successfully utilized by the World Health Organization (WHO) in determining influences such as 
socio-economic, biological, and physical elements associated with infectious diseases, more 
specifically in relation to the transmission of human immunodeficiency virus (HIV) within 
specific locations (World Health Organization, 2014).  The triad model factored in the host, 
agent, and environment that identified intrinsic causes which had an affect the equilibrium of the 
triad model.  The agents were composed of biological, physical, mechanical components; while 
the host consists of age, gender, ethnicity, customs, religion, and genetics.  Lastly, the model 
factors in environmental constituents which were comprised of physical, exposure, social, and 
economic elements.  Interaction between the three triad factors of the model illustrated causation, 
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Figure 1. Advanced model of the triangle of epidemiology. Adapted from Foundations of 
Epidemiology (2nd ed. p. 14), by A.M. Lilienfeld and D.E. Lilienfeld, 1980, New York, NY:  
Oxford University Press.  
Significance of the Study 
 The findings of the research study provided an analytical explanation for the forces that 
drove Medicare patients’ LOS.  This study explained the logic behind costs applied for the 
duration of hospitalization, in addition to delivering a foundation for policy reform by providing 
analyzed data to Medicare and policy decision-makers to amend guidelines for reimbursement 
rates and LOS (Ginsburg & Rivlin, 2015).  The research is methodologically significant because 
it employs current codes from the 10th revision of the International Statistical Classification of 
Disease and Related Health Problems (ICD-10), which could result in higher accuracy of 
medical diagnoses than was possible prior to ICD-10 (Medicaid.gov, 2016; Qureshi, Adil, 
Zacharatos & Suri, 2013).  The importance of the research is substantial, given its potential to 
provide an explanation for trends in Medicare LOS as reported in previous Centers for Medicare 
and Medicaid (CMS) documents (Maeda, Henke, Marder, Karaca, Friedman & Wong, 2014).   
The study is significant for healthcare administrators because the findings may assist in 
standardizing reimbursement rates for Medicare recipients without placing limitations on the 
patients’ LOS, and may assist in improving patient outcomes.  The research is also significant 
because it provides further examination into the cost-shift theory for Medicare reimbursement 





These policies contain incentives for healthcare to optimize reimbursement that may lead to 
efficient lengths of stay for Medicare recipients (White, 2013). The research study is also 
significant because the results uncovered the logic behind particular Medicare states refusing to 
cover extended LOS, while LOS and reimbursement rates in other states exhibit dramatic 
dissimilarities.  The research is meaningful due to the potential for revealing the rationale for a 
government entity not being transparent across the board, as well as indicating whether there was 
any improvement to decrease the fluctuations (Medicaid.gov, 2016). 
 Nature of the Study 
The nature of the study involved quantitative methodology and cross-sectional design. 
Medicare patients with hypertension who were hospitalized during the period between 2011 and 
2013 were selected for analysis.  A regression analysis was utilized to estimate the association 
between the dependent variable, LOS, and reimbursement rates while controlling for covariates. 
The analysis allowed the researcher to determine a relationship between the dependent variable 
and the independent variables utilizing a multivariable logistic regression. The findings assisted 
in reducing the gap in the literature regarding the determinants of Medicare lengths of stay 
(Busby, Purdy & Hollingworth, 2015).   Predictors of LOS for Medicare recipients with 
hypertension were also identified.  An epidemiologic triad approach guided the analysis by using 
variables about person, place, and time (Rohrer, Grover & Moats, 2013). 
Definition of Terms 
The list below provides detailed definitions of terms utilized throughout the course of the 
study. 
Reimbursement rate: Term used for the payments that hospitals and physicians receive in 
return for services rendered to Medicare beneficiaries (MedicareResources.org, 2015) 





Inpatient days are calculated by subtracting day of admission from day of discharge (Medical 
Dictionary, 2017). 
Blood pressure:  Term used to describe two measurements of systolic and diastolic, blood 
pressure is the force exerted by circulating blood on the walls of blood vessels and is an 
important component of vital signs in human beings (Medical Dictionary, 2017). 
Hypertension:  Term used to define repeatedly elevated blood pressure exceeding 140 
over 90 mmHg.  A systolic pressure above 140 or a diastolic pressure over 90 (Medicinenet.com, 
2017). 
Borderline hypertension: Blood pressure measurement that lies between the highest 
acceptable normal blood pressure and hypertensive blood pressure (Moser, 2007). 
Chronic hypertension:  Long term condition in which blood pressure is higher than 
normal range blood pressure of 140/90 (Medical Dictionary, 2017). 
Inpatient level of care:  Term used to describe the intensity of medical care being 
rendered by a physician or healthcare facility (Medical Dictionary, 2017). 
Race:   Refers to groups of people who have differences and similarities in biological 
traits deemed by society to be socially significant, meaning that people treat other people 
differently because of them (Merriam-Webster.com, 2017). 
Ethnicity: The fact or state of belonging to a social group that has a common national or 
cultural tradition.  refers to shared cultural practices, perspectives, and distinctions that set apart 
one group of people from another. That is, ethnicity is a shared cultural heritage (Merriam-
Webster.com, 2017). 
Diagnosis-related group (DRG):  A statistical method of classifying inpatient stays into 





Centers for Medicare and Medicaid (CMS):   A segment of the Department of Health and 
Human Services (Centers for Medicare and Medicaid Services, 2017) 
Medicare: A single-payer, national social insurance provider governed by the United 
States government (Centers for Medicare and Medicaid Services, 2017) 
Assumptions 
The study was contingent upon identifying current data displaying variations among 
reimbursement rates for Medicare hypertensive patient’s LOS.  Dissimilarities were exhibited on 
the region in which data is derived to express fluctuations in reimbursement rates for Medicare 
recipients. The utilization of Medicare in conjunction with private insurance further provided 
clarification in the differentiation of rates of Medicare reimbursement for hypertensive patients.  
Significant governmental budgetary restraints within Medicare were vital factors in reduced LOS 
(Ishak, Stolar, Hu, Alvarez, Wang, Getsios & Williams, 2012).  Additionally, various elements 
that contributed to hypertension among Medicare patients could not be gauged, such as patients 
who are genetically prone to hypertension as well as diet, exercise, environmental factors, 
lifestyle choices, and stress. 
Scope and Delimitations 
 The researcher examined Medicare beneficiaries across the United States who were 
medically diagnosed with hypertension.  Medicare beneficiaries with hypertension were chosen 
as a target population because hypertension continues to be the leading cause of chronic disease 
commonly labeled as the silent killer (Grabowski, Huckfeldt, Sood, Escarce, & Newhouse, 
2012).  The research study incorporated a secondary dataset from Healthcare Cost and 
Utilization Project (HCUP) nationwide database of the National Inpatient Sample (NIS) for 2011 
to 2013.  The research study was analyzed for the years 2011 to 2013 for the U.S. population. 





rates for hypertensive Medicare beneficiaries as well as clarification while controlling for 
geographic location, age, gender, year, race/ethnicity, and medical comorbidities.  The research 
study encompassed all Medicare beneficiaries including those who were categorized as 
physically handicapped, and therefore qualified for Medicare benefits. 
The previous sections of this study have provided an overview of problematic 
implications of Medicare reimbursement and the LOS for hypertensive patients. It also presented 
a relevant purpose of conducting a research aimed at presenting a social significance for a 
targeted population utilizing a triad methodology.  Section 1 has also imparted medical 
terminology that was utilized throughout the course of the research study.  Likewise, the research 
questions and nature of the study have been presented to provide clarity concerning the basis of 
the research with an epidemiological foundation.   
A further in-depth analysis of the research questions and literature review addressing the 
gap in literature was targeted in this study, and relevant social impacts on the Medicare 
population. The literature review establishes a theoretical framework by utilizing a triad method, 
indicates the need for research on LOS and reimbursement rates while recognizing aspects of 
previous research studies on related topics.  The literature review also identifies new techniques 
for interpreting previous research, recognizes gaps within the literature, and justifies the need for 
further research that specified a current timeline.  Finally, the literature review identifies how 
LOS and reimbursement rates have been researched, while providing interpretations of previous 









Medicare was signed and implemented in 1965 by former president Lyndon B. Johnson.  
Benefits for Medicare beneficiaries are initiated at the age of 65; however, beneficiaries may 
enroll up to 3 months prior to their 65th birthday to ensure a timely enrollment (Centers for 
Medicare & Medicaid Services, 2017).  Establishing the rate of reimbursement and the LOS for 
Medicare recipients required additional examination by region due to the variations within 
Medicare policies.  In accordance to each state, these variations produce distinctive differences 
in healthcare coverage for LOS within each state due to state Medicare policies (Medicare.gov, 
2017).  Ongoing research has built on information provided by the Centers of Medicare and 
Medicaid (CMS) to capture factors that contribute to the LOS. Some of the elements incorporate 
medical diagnosis, morbidity, Medicare in conjunction with additional private insurance, and 
participation of the provider.  These factors which contribute to the LOS for Medicare recipients 
have been explored to determine appropriate LOS (Qureshi, et al, 2013).  Background 
knowledge of reimbursement rates among Medicare recipients also took into account the total 
fees associated with the LOS.   
The differences in state Medicare policies were elements contributed to variations among 
regions for LOS and expenses.  The differences drove from hospitalization which were closely 
associated elements that required closer assessment within the research study (Qureshi, et al, 
2013).  Analyzing data provided within the secondary data set had the potential to unveil the gap 
of how certain components contribute to the LOS for person, timeframe, and location.  The 
research had the capability to acquire a better understanding of the reasoning for discrepancies in 
the LOS for Medicare recipients (Qureshi, et al, 2013).  The findings from previous research 





patients who were hospitalized for longer a duration have higher rates in the national estimates 
with greater hospitalization charges (Busby, Purdy & Hollingworth, 2015).   
These components had the potential to inform Medicare policy decision-makers to 
become more cognizant of the variations in hospital charges and LOS for Medicare recipients 
(Busby, et al, 2015).  Likewise, further exploration may contribute to the overall health of the 
Medicare hypertensive population by aiding in the decline of the national healthcare deficit 
(McLaughlin & Olson, 2012).  Further analysis of the research study likewise may assist in 
identifying the elements of variation along with determining factors of extended hospital 
duration. Additional research attempted to conclude the impact of hospital costs and LOS has on 
the healthcare economy.   
Strategies Used for Literature Review 
 The intention of the research study was to ascertain plausible explanations for variations 
in reimbursement rates and LOS for hypertensive Medicare patients.  Exploring online resources 
that were peer-reviewed on BioMed Central, PubMed, government reports, literature matrix 
(created by the researcher to enable quick comparisons among articles to determine the scope), 
Google Scholar, and EBSCOhost will be utilized.  Additional relevant resources utilized were 
the Centers for Medicare & Medicaid (CMS), National Institute of Health (NIH), and evidence 
table.  Research articles that were relevant dating greater than five years were utilized merely for 
the purpose of previous were established research.  The terminology that was utilized to acquire 
relevant literature were LOS, reimbursement rate, hypertension, supplemental private insurance, 









 A review of related literature exploring the reimbursement rates and LOS for Medicare 
patients disclosed the need for further research in determining the variations in LOS and 
reimbursement rates.  Variations in hospital charges across the United States were significantly 
higher for private insurance providers as opposed to Medicare (Maeda et al, 2014).  The 
reimbursement rates factored in market-based tactics to ensure payment reform which assisted in 
variations in reimbursement rates (Yoo et al, 2012).  Additional research was conducted to 
determine the LOS strategic guidelines to determine the reduction rate for Medicare patients 
LOS (Martinez-Martinez et al, 2013).  Additional factors that were associated with the LOS for 
Medicare patients with hypertension entailed costs accompanied by comorbidities that increased 
LOS, as well as admission and re-admission rates (Machnicki et al, 2011).  
  Demographics also influence the rate of reimbursement per region; however, determining 
the calculations and guidelines that are applicable to Medicare patients remained to be 
standardized across the United States for LOS (Busby et al, 2015; Ku-Chou et al, 2012).  An 
increased LOS additionally adds to outlier and costs associated with inpatient management; 
therefore, driving the overall cost of inpatient stays beyond the estimated costs (Caravan, 2013; 
Sawant et al, 2013).  Over utilization of the emergency departments has warranted additional 
research to explore per diem cost and LOS for hypertension and hypertension related illnesses 
such as ischemic attacks, and vascular failure (Ishak et al; 2012; Singh et al, 2016).  Previous 
literature has not addressed the variables utilizing the triad approach in further determining the 
reimbursement rates and LOS for hypertensive Medicare patients.  The epidemiological 
approach was suited to addressing the gap in literature, and providing knowledge of the process 





RQ1:    Are reimbursement rates related to the LOS for Medicare patients with                 
hypertension as the reason for admission after controlling for geographic region, age, year, 
gender race/ethnicity, and diabetes? 
H1: The hospital reimbursement rate is related to the LOS for Medicare patients with 
hypertension as the reason for admission when controlling for geographic region, age, year, 
gender, race/ethnicity, and diabetes. 
H2:  The hospital reimbursement rate is not related to the LOS for Medicare patients with 
hypertension as the reason for admission when controlling for geographic region, age, year, 
gender, race/ethnicity, and diabetes. 
RQ2:    Are the hospital reimbursement rates associated with prolonged hospitalization               
for Medicare patients admitted for hypertension when controlling for geographic region, age, 
year, gender, race/ethnicity, and diabetes? 
H3:  The hospital reimbursement rate is associated with prolonged hospitalization for Medicare 
patients with hypertension as the reason for admission when controlling for geographic region, 
age, year, gender, race/ethnicity, and diabetes. 
H4:  The hospital reimbursement rate is not associated with prolonged hospitalization for 
Medicare patients with hypertension as the reason for admission when controlling for geographic 
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Prices are significantly higher 
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cost and healthcare burden 
 
Suh et al, 2014 
Effect of health 
insurance type on 
healthcare utilization 
in patients with 
hypertension: a 
national health 













The pattern of higher  
healthcare utilization among 
MA patients persists even 











Medicare Hospitalization Cost 
 Hospital charges accrued by Medicare patients are estimated total payment amounts that 
encompass the diagnosis related group (DRG) cost, total charge per diem, Medicare primary 
payer cost, coinsurance, deductible, and DRG outlier total (Centers for Medicare & Medicaid 
Services, 2017).  CMS utilized data on hospital-specific expenses for over 3,000 hospitals 
nationally.  Each healthcare facility applied government specified Medicare Severity Diagnosis 
Related Group (MS-DRG) annually to itemize services rendered to Medicare patients.  Nearly 
75% of Medicare discharges were represented by the MS-DRG which accounts for more than 7 
million inpatient prospective payment system (IPPS) discharges (Centers for Medicare & 
Medicaid Services, 2017).  Medicare likewise applied supplemental payments to the healthcare 
facilities commonly known as outlier payments which were formulated to safeguard against 
substantial economic loss. 
Medicare Payment 
Medicare reimbursements for hypertensive patients are categorized into groups 
determined by payer status such as denials (i.e., medically unnecessary or non-covered 
care/patient), delays (i.e. additional review required), and payments forthcoming (Mehta, Flores, 
Thompson, & Nathan, 2016).  Payment validation within each healthcare organization entails 
eligibility verification, metrics, benchmarking, and cost methodology in an effort to remain 
within a model of care and reimbursement.  Billing and coding for Medicare reimbursement 
involves five-digit current procedural terminology (CPT) and modifiers for appropriate coding 
which also permit accuracy (Medicare.gov, 2017).  Reimbursement expectations vary depending 
on the appropriate charge capture, coding and claims submission that each healthcare facility 
submits to Medicare by accepting applicable billing.  Each Medicare claim presented by a 





revenue cycle.  The utilization of DRG coding and current ICD-10 compliance are more efficient 
means of providing a specific charge structure due to the capability of the process to deliver 
accuracy and compliance solutions (Medicare.gov, 2017).  Reimbursement and revenue cycle 
optimization for Medicare patients are continuously undergoing procedures that should minimize 
denied and delayed compensation.  Rejection resolutions for payment posting and denial analysis 
are predetermined by traditional and current coding practices that are in conjunction with 
regulatory compliance.  As compensation for medical care is acquired, many healthcare 
organizations are contracted to utilize a process termed super billing (charges completed by 
provider) in an effort to obtain expedited payment (Medicare.gov, 2017).   
Demographics and clinical predictors contribute to LOS for Medicare patients depending 
on the state and local parameters established in outlier assessments.  Regional specifications may 
likewise interject the rate of admissions, and readmissions for predictors such as hypertension, 
gender, age, and race/ethnicity (Chang, Tseng, Weng, Lin, Liou, Teng-Yeow & Tan, 2002).  
Influential factors in the rate of Medicare reimbursement operate in conjunction with recurrent 
cost analysis to alleviate intermittent and distinct variations.   
Although consistency is an imminent segment of Medicare reimbursement; elements such 
as location and medical severity greatly influence general revenue cycle components (Chang et 
al, 2002).  Demographic and medical characteristics of patients whose LOS was assessed 
disclosed that the median for age was 66 of which 58.5% were men and 41.5% women (Chang, 
Tseng, Weng, Lin, Liou, Teng-Yeow & Tan, 2002).  The median LOS was 7 days, which also 
encompassed other variables such as smoking, stroke, severity of stroke, neurological 





Pulmonary hypertension (PH) fees for Medicare patients incurred significant costs due to 
readmissions, and required a longer duration of hospitalization.  Many PH patients often 
encounter a higher readmission rate within 1-year due to the chronic pulmonary disease 
encountering many complications (Burke et al, 2015).  The average cost for Medicare patient 
hospitalization from PH was just over $46,000 in 2011 with the average LOS was approximately 
11 days.  The cost and LOS for admission were significantly higher for Medicare versus 
commercially insurance with the difference being just under $20,000 per year, and with a four-
day variation in LOS (Burke et al, 2015).   
From 1989 to 2014, the rate of Medicare spending increased approximately 5.5% per 
year, placing it at a rate 6.3% behind the annual rate of commercial insurance per person.  
Additionally, from 2010-2015 the spending rates were somewhat analogous for Medicare, and 
commercial insurance with an annual increase of only 1.4% over the duration of a six-year time 
frame (Cubanski & Neuman, 2016).  The projected spending expenditure for Medicare between 
2015 and 2025 is 7.1% which is a 4.4% gain for the annual growth between 2010 and 2015 
(Cubanski & Neuman, 2016). 
Supplemental Private Insurance 
Supplemental insurance in conjunction with Medicare coverage provides patients with a 
broader range of medical coverage, and places the provider at a higher rate of reimbursement 
with the dual coverage.   Medicare revenue is provided by numerous sources such as general 
revenue, payroll taxes, beneficiary premium, social security taxation, interest, and state payments 
(Medicare.gov, 2017).  Medicare supplemental insurance (Medigap) provides Medicare patients 
with additional coverage that encompasses copays, coinsurance, and deductibles (Medicare.gov, 






Figure 2.  Average annual growth rate percentage in Medicare and private health insurance 
spending, 2000-2015, by Kaiser Family Foundation. 
Source: Cubanski & Neuman, The Facts on Medicare Spending and Financing.  Kaiser Family 
Foundation analysis of Medicare spending data from Boards of Trustees; private health insurance 
spending data from the CMS National Health Expenditures data.  
 
 The Medicare annual growth rate and private health insurance indicated a decrease from 
2010-2015 as opposed to 2000-2010 (Cubanski & Neuman, 2016). Primary insurance principal 
purpose is to provide reimbursement first, and the beneficiary will be responsible for the 
remainder of costs incurred.  Secondary insurance provides reimbursement for a portion or the 
remainder of the cost after primary insurance has been compensated.   Medicare beneficiaries 
that possess both primary and secondary insurance coverage with one being private insurance 
have the option to enroll in Medicare Part A.  Medicare Part A utilized in conjunction with 
private insurance provides the beneficiary with medical coverage either free of charge or with a 
low premium and no out-of-pocket limitation (Medicare.gov, 2017).  Additional Medicare 
coverage such as Part B can be applied as a secondary insurance for beneficiaries in conjunction 
with health insurance from an employer.   
Total Medicare spending Medicare per captia spending PHI per capita spending
2000-2010 9 7.4 7.2
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Figure 3.  Projected average annual percentage growth rate in Medicare and private health 
insurance spending, 2000-2015 by Kaiser Family Foundation. 
Source: Cubanski & Neuman, The Facts on Medicare Spending and Financing.  Kaiser Family 
Foundation analysis of Medicare spending data from Boards of Trustees; private health insurance 
spending data from the CMS National Health Expenditures data. 
 
Enhanced management for Medicare patients such as age and health specified treatment 
have the capability to assist in progression toward a reduction of exorbitant and onerous LOS 
(Burke et al, 2015).  Medicare and primary health insurance spending that operates collectively 
possess a greater chance of claims being reimbursed; however, the total Medicare spending far 
exceeds private health insurance per capita while there is only a marginal difference in Medicare 
and PHI per capita (Cubanski & Neuman, 2016).   Controlling for Medicare costs can be taxing; 
however, when additional healthcare coverage is applied such as Medigap, TRICARE, long-term 
care insurance, the Federal Employees Health Benefits Program (FEHBP), and American 
Association of Retired Persons (AARP) expenditures can be curtailed.  The type of insurance has 
an influence on patient frequency, resources, preventative utilization, and more explicitly on 
LOS (Suh, Kang, Kim & Shin, 2014). 
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The rate of Medicare reimbursement heavily relies on funding from the federal 
government and states (Medicare Resources, 2012).  The Medicare-to-Medicare fee gauges a 
healthcare organization fees within each state, and adjusts reimbursement rates accordingly per 
service state or region (Medicaid.gov, 2017).  The Medicare fee schedule is comprised of 
itemized fees utilized to reimburse providers, and provide a fee maximum for the services 
rendered.  The services rendered may include laboratory services, durable medical equipment 
(DME), ambulatory services, primary care services, hospitalization, and much more that are all 
assessed with the Medicare fee schedule (Medicaid.gov, 2017).   
The Medicare fee schedule and hospital LOS outlier management process administers 
particular guidelines to financing within a healthcare system.  During the process of healthcare 
administration and Medicare outlier consulting, it is determined the maximum LOS for Medicare 
patients will be accordance to the medical diagnosis (Freitas, Silva-Costa, Lopes, Garcia-Lema, 
Teixeira-Pinto, Brazdil & Costa-Pereira, 2012; Medicare.gov, 2017).  Nearly 4.0% of high LOS 
outliers accounted for 19.2% of  total hospitalization with academic hospitals having a longer 
LOS and readmissions (Freitas et al, 2012). 
Inpatient Pricing 
Inpatient pricing is contingent on the complexity of the healthcare organization and a 
patient’s medical diagnosis as well as the determinant of LOS (Maeda, Henke, Marder, Karaca, 
Friedman & Wong, 2014).  A patient’s intricate diagnosis is assessed by medical professionals 
and administration to ensure that the Medicare guidelines are taken into consideration when 
applying hospital pricing.  Likewise, consideration is applied to the costs that will vary 
systematically with the determined LOS, location, and the complexity of a patient’s medical 





Length of Stay 
 The LOS for Medicare patients is determined by the medical diagnosis, DRG, 
demographics, and government guidelines that are applicable to each healthcare organization.  
The duration for patient stay is categorized into the average LOS and the geometric LOS.  The 
difference between the average LOS and geometric mean LOS is that the average LOS is the 
calculations a hospital defines as the duration a patient stays within an occurrence during 
hospitalization (Freitas et al, 2012).  The average LOS is also analyzed by the number of patients 
with similar/same diagnosis with a LOS divided by the total number of patients admitted over 
the past 12 months.  Whereas, the geometric mean LOS is a computed by multiplying all of the 
LOS and using the nth root of the number of patients (Freitas et al, 2012). 
Admission Rate 
The admission rate is constantly rising due to the age of Medicare beneficiaries, and the 
ongoing medical conditions associated with an aging or physically handicap population 
(Canavan, 2013).   Current trends in hypertensive patients are often coupled with other chronic 
illnesses such as diabetes, kidney failure, and cardiovascular disease (Lipska, Ross, Wang, 
Inzucchi, Minges, Karter, Huang, Desai, Gill, Krumholz, 2014).  These illnesses have directly 
impacted the rate in which Medicare patients are hospitalized and treated in an effort to 
effectively care for older adults or the physically disabled (Busby, Purdy & Hollingworth, 2015).  
Additionally, the LOS is influenced by admission rate as well as the readmission of hypertensive 
patients with combined sickness.  Hospitalization costs and LOS for hypertensive patients with 
pulmonary arterial hypertension estimated just over $30,000 with the average LOS of 11 days.  
The total costs for patients that were readmitted was approximately $71,000 with a LOS of 24.5 







The readmission rate of hypertensive Medicare patients is calculated by estimating the 
number of patients who return for the same diagnosis within 30 days of the previous discharge.   
The readmission rate can be further examined by age, gender, and demographic location 
(Dartmouthatlas.org, 2017).  This data provides detailed reimbursement rates for hospital 
admission and readmission for various healthcare facilities such as skilled nursing facilities and 
outpatient establishments for reimbursement rates on behalf of the health services rendered. 
Currently, healthcare organizations with low inpatient admission rates are commonly 
located within rural regions; however, these regions have been recorded as having lower rates of 
mortality (Minemyer, 2017).  The mortality rate for Medicare patients that were discharges 
within seven days was 0.12%, which contributed to approximately 10,000 unexpected deaths 
annually (Minemyer, 2017).  Hospitals with higher admission rates which discharged nearly 85% 
of Medicare patients incurred a death rate of 3.4% higher than healthcare organizations with a 
lower admission rate (Qureshi, Adil, Zacharatos & Suri, 2013). 
Inpatient Management 
 Since 2012 there has been a nationwide decline in the admission and readmission rates 
for Medicare patients.  This decrease may be a direct result of a plethora of healthcare process 
improvement techniques, and quality of care initiatives that have been implemented within many 
healthcare organizations (Martínez-Martínez, Martínez-Sánchez, Fuentes, Cazorla-García, Ruiz-
Ares, Correas-Callero, Lara-Lara & Díez-Tejedor, 2013; McLaughlin & Olson, 2012).  A more 
comprehensive exploration for the decline in readmission still requires further investigation 
(Sawant, Mills & Dhingra, 2013).  The number of Medicare admissions has decreased from 11.4 
million in 2007 to 10.4 million in 2012, and readmission rate from 2.1 million in 2007 to 1.9 






Geographic elements consistently have an effect on the rate of Medicare reimbursement, 
mortality, LOS, admission, and readmission rates.  Medicare geographic adjustment factors have 
been utilized in an effort to ensure that healthcare providers and healthcare organizations are 
reimbursed sufficient payment for the care provided (Geographic Adjustment Factors in 
Medicare Payments, 2011).   Some geographic factors also consist of adjustments of fee-for-
service reimbursement rates in accordance to geographic location to control variations among 
rural and metropolitan regions.  The adjustments attempt to assist in providing reimbursements 
that reflect on local costs of rendering care.  This process aids in ensuring that Medicare provides 
adequate payment per region according to the geographic practice cost index (Edmunds & Sloan, 
2011).   
In an effort to enhance accuracy in geographic adjustments, Medicare attempts to gauge 
reimbursement according to the local labor market, in which healthcare providers manage and 
contend for employees (Busby, Purdy & Hollingworth, 2015).  With the utilization of labor 
market data, Medicare can make certain that broadening healthcare providers to be incorporated 
in computing a wage index, and fluctuations in pricing (Edmunds & Sloan, 2011).  The 
fluctuation in pricing per region may directly impact the rate of reimbursement, and the LOS 
when healthcare organizations are striving to adhere to Medicare guidelines.  A conceptual 
rationale for utilizing data from a healthcare sectors versus industry-wide can assist in improving 
accuracy in geographic adjustments and address concerns conveyed by stakeholders.  The 
Institute of Medicine (IOM) evaluates the accuracy of geographic adjustments factors, 
methodology, data, and the effects adjustments have on Medicare reimbursement rates.  The 
evaluations assist in the quality of care, higher rate of reimbursements, and overall health of the 






 Medicare patients who have been diagnosed with hypertension can be covered under 
Medicare Part B and D.  Medicare covers patients for screening that assist in alleviating stroke 
which may be directly caused from hypertension prevalence (Medicare.gov, 2017).  
Hypertensive patients account for nearly 70 million people across the U.S., and over $42.9 
billion was spent in 2010 to treat hypertensive patients.  Approximately 1 in every 3 adults is 
clinically diagnosed with hypertension, and the prevalence increases with an aging population 
(CMS.gov, 2017).  Within the age range of 18 to 39 nearly 7% of the population is diagnosed 
with hypertension, while there is nearly 67% with hypertension over the age of 60.  Hypertension 
is the leading cause of chronic disease mortality in the U.S. due to uncontrolled high blood 
pressure resulting in approximately 1,000 deaths daily (CMS.gov, 2017). 
Table 1 
Classification of Hypertension 
___________________________________________________________________ 
Blood Pressure  Systolic Blood Pressure Diastolic Blood Pressure 
Classification   (SBP) – mmHG  (DBP) – mmHG 
____________________________________________________________________ 
Normal    <120     <80 
Pre-hypertensive   120-139   80-89 
Stage 1 Hypertension   140-159   90-99  
Stage 2 Hypertension   >160    >100 
____________________________________________________________________ 
Note. 2004 Joint National Committee on Prevention, Detection, Evaluation & Treatment 
of High Blood Pressure. Source: National Heart, Lung, and Blood Institute (NHLBI), 
National Institutes of Health. http://www.nhlbi.nih.gov/guidelines/hypertension 
 
Hypertension accounted for nearly 55% of Medicare fee-for-service in 2012.  The 
disparities associated with elderly hypertension were among the highest in the African-American 
population at 63%, followed by 56% in the Asian/Pacific Islander community, and 55% of Non-







Source: Centers for Medicare & Medicaid Services. Chronic Condition Data Warehouse (CCW) 
Centers for Disease Control and Prevention. Hypertension among Adults in the United States: 
National Health and Nutrition Examination Survey, 2011-2012. 
Centers for Medicare & Medicaid Services. Chronic Conditions.  
 
Despite the plethora of medications and treatments to combat hypertension, high blood 
pressure still remains to be fully controlled or eradicated among Medicare patients.   Some 
factors that accompany prevalence with the Medicare population are non-adherence to prescribed 
treatment, patients who are genetically pre-disposed to hypertension, lack of awareness that the 
chronic disease exists due to insufficient treatment, socio-demographic, and clinical 
characteristics (CMS.gov, 2017).  Hypertension prevalence that addresses the variation in 
clinically diagnosed Medicare patients among socio-demographics has the capability to 
strengthen regulations associated to quality of care as well as assist in providing standardization 
in LOS, admission, and reimbursement rates.  By applying industry wide consistency, Medicare 
policies have the potential to employ quality measures in an effort to develop regulated 
specifications across the healthcare continuum (Mastragelo, 2014). 
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Hypertension among Medicare patients is commonly accompanied with other chronic 
diseases such as diabetes, ischemic heart disease, high cholesterol, renal failure, stroke, arthritis, 
and dementia (Moser, 2007).  The most prevalence triad chronic condition combination is 
ischemic heart disease, hypertension, and diabetes with 33.7% prevalence.  This triad has a per 
capita spending expenditure of nearly $20,000 per patients; however, the most costly triad is 
stroke, chronic kidney disease, and asthma (Semilla, Chen, Dall, 2015). 
The reduction in mortality rate among Medicare patients post implementation of 
Medicare Part D assisted in the reduction of deaths by 2.2% annually.  Medicare Part D 
enhanced drug coverage which aided in comprehensive coverage, and increased utilization of 
hypertensive medication with treatment.  Since the implementation of Part D, approximately 
200,000 Medicare beneficiaries have increased longevity by an average of 3 years (CMS.gov, 
21017).   
Hypertension mortality and geographic variations are consistent in LOS; furthermore, 
placing a higher mortality rate in rural regions.  The rate of hypertension mortality during re-
admission was decreased by 4% in 2013 as opposed to 1% for initial hospitalization (Freeman, 
Wang, Akar, Desai, Krumholz, 2017).  In 2013 Medicare fee-for-service patients who were 
admitted and treated with more cost consuming treatments; however, the quality of care rendered 
results greater than 30-day readmissions with a lower mortality rate (Freeman et al, 2017). 
Hypertension ED Utilization 
Utilization of the emergency department (ED) and inpatient health services for 
hypertension related occurrences within the United States has increased since 2009 from 920,984 
to 1,041,233 for patients with hypertension as the primary diagnosis (Singh & Yu, 2016).  





(Williams, 2012).  Of the over one million hypertension related visits to the ED, 23% of the 
patients were hospitalized for further monitoring, testing, and treatment.  During the course of 
the last four years there has been a 13% upsurge in ED utilization for hypertension documented 
cases that has added to national health care deficit (Singh & Yu, 2016).  One in seven adults 
classified as hypertensive that utilizes the ED is uninsured, which is estimated at 4 million 
nationwide (Brooks, 2016).  Approximately 15% of hypertensive related visits to the ED were by 
those who were uninsured and an addition 23.4% utilized Medicaid (Centers for Disease Control 
and Prevention.gov, 2015).  The individuals who received Medicaid coverage were more likely 
to utilize the ED than those who had private insurance (Centers for Disease Control and 
Prevention.gov, 2015).  Despite the plethora of medical therapy for hypertension treatment and 
monitoring, it remains an inadequate system for cost-containment within the U.S., thus creating a 
negative impact on the health care economy (Centers for Disease Control and Prevention.gov, 
2015).  Of the ED visits due to hypertension associated instances 11% of patients were 
hospitalized and an additional 13% transferred to other health care facilities (Singh & Yu, 2016).  
Nearly 18% of uninsured hypertensive patients neglected visits to a primary care physician, and 
thus utilized the ED as means of primary care treatment (Brookes, 2016).  
 
Figure 5 
















 The reimbursement rate for hypertensive patients receiving Medicare benefits varied 
depending on a number of factors as explored within the literature review.  These variations were 
comprised of several components that assisted a geographic region in reducing readmissions, 
assigning the appropriate LOS, and adequate reimbursement rate per location.  Medicare 
guidelines are practiced in accordance to state and governmental regulations; however, the 
guidelines were not consistent across all states.  Geographic adjustments are one of the many 
reasons that reimbursement variations occur with specified regions (Geographic Adjustment 
Factors in Medicare Payments, 2011). 
 Additional insurance utilized in conjunction with Medicare supplemental (Medigap) 
offered beneficiaries with a broader range of coverage and  alleviates the responsibility of 
disbursing out-of-pocket funds (Medicare.gov, 2017).  Approximately  4.0% of high LOS 
outliers accounted for 19.2% of extended stay which caused a longer LOS and a greater 
probability for readmissions (Freitas et al, 2012).  Healthcare facilities with high admission rates 
discharged nearly 85% of Medicare patients triggering a death rate of  3.4% higher than hospitals 
with a low admission rate  for hypertensive  patients (Qureshi, Adil, Zacharatos & Suri, 2013).   
The literature review focused on exploring reasoning for variations per geographic region 
and the LOS for Medicare hypertensive patients.  The literature also exhibited factors of 
Medicare that have implications on healthcare costs such as prevalent chronic diseases that are 
expressed in an aging population as well as groups (ethnic/race, gender, region) that were 
impacted by hypertension.  The variations in acceptable LOS per region also had an influence of 
the rate of reimbursement on behalf of Medicare beneficiaries.  Likewise, the utilization of the 
ED interjected and is an initial dynamic in the LOS along with admission or readmission.  





additional costs.  The significance of the research may provide rationale for a government entity 
consistency nationwide, and whether there has been any improvement to decrease the 
fluctuations (Medicaid.gov, 2016).  The need for further research is based upon further strategies 
that are required to determine the reduction of LOS, the significant price variation in Medicare 
and private insurance, the demand for a market-based approach or payment reform, and 
additional research pertaining to the impact of comorbidities on reimbursement and LOS as a 
U.S. healthcare burden (Qureshi et al, 2013).  Furthermore, seeking determinants of extended 
hospitalization and concluding the effect on costs that impacted the LOS for Medicare patients 
nationwide are gaps that were explored.   
The research had the capability to provide a positive social impact by providing new 
reimbursement standards that will benefit Medicare recipients. Likewise, with enhanced 
guidelines implemented by Medicare it had the potential to require flexibility in reimbursement 
for treatment surrounding hypertension, and gauging the essentials for targeted populations 
which may increase the rate of reimbursement (Suh et al, 2016).  Strengths within the research  
unveiled the need for maximizing the LOS allotted by healthcare organization and Medicare 
reimbursement guidelines in an effort to become more cost efficient while meeting the healthcare 
needs of the population. However, the drawback of maximizing the LOS for hypertensive 
patients may contribute to the already rising deficit of the healthcare economy nationwide.  
Increased LOS may also place a strain on the rate of reimbursement considering there was a flat 
fee rate for the services rendered despite the increasing number of Medicare patients with 
chronic diseases.  An opportunity presented was the possibility of increased reimbursements and 
extended LOS for patients with medical necessity; however, the threats of encompassed the 





Section 2: Research Method 
Introduction 
 The research method that was applied to assess the hypothesis was a quantitative 
multivariate analysis.  The logistic regression analysis testing determined that there was a direct 
correlation in hospital reimbursement rates being associated with prolonged hospitalization 
and/or reimbursement rates related to the LOS for Medicare patients with hypertension.  This 
section presented the research methodology, setting, size, region, target population, instruments 
and materials utilized to assist in the analysis.  Multiple studies were explored that were 
comparable and consistent in controlling for similar covariates, LOS and reimbursement rates for 
Medicare patients with hypertension. 
Research Design 
 A logistic research design was applied to the study to present correlation between 
variables as well as an epidemiological model consisting of person, place, and time.  A 
quantitative design assisted in identifying the extent of the correlation and factors within the 
target population.  A quantitative analysis verified the data presented via the use of statistical 
package for the social sciences (SPSS).  The design assisted in determining trends within 
Medicare reimbursement rates and LOS factors associated with hypertensive patients.  The 
research design likewise assisted in quantifying data from the target population, and measuring 
the incidence from multiple aspects within the sample including exploring additional findings.  
The quantitative research was utilized in determining variations in reimbursement rates and LOS 
by the region in which Medicare benefits were applied.  It also explored applicable results that 







Setting and Sample 
 Data were analyzed that represented of hypertensive patients who had received Medicare 
benefits from 2011 to 2013.  A secondary data set that was utilized in the research study was 
acquired from the Healthcare Cost and Utilization Project (HCUP) nationwide database of the 
National Inpatient Sample (NIS) for the duration of 2011 - 2013.  In conjunction with the 
secondary data set supplied by HCUP-NIS examination of the reimbursement rates for LOS for 
Medicare patients was used while simultaneously controlling for covariates categorized from the 
secondary data set (Qureshi, et al, 2013).   To obtain secondary data from HCUP, a mandatory 
data use agreement course was completed that addressed the key aspects of utilizing secondary 
from the HCUP website (Agency for Healthcare Research and Quality, 2016).  A certificate code 
was then issued to access the secondary dataset  electronically, and  provided authorization for 
utilizing data to conduct testing for the research setting that concentrated on the U.S. population 
of hypertensive Medicare patients. 
Target Population 
 The research focused on Medicare recipients who were medically diagnosed as 
hypertensive.  The inclusion of hypertensive Medicare patients was necessary in order to assess 
the hypothesis, and determine whether there was a correlation among reimbursement rates and 
LOS for hypertensive patients.  Patients who were not medically diagnosed with hypertension or 
receiving Medicare benefits were excluded from the research study.  The research did not 
exclude patients based upon location, gender, ethnicity/race, age, physical disability, or pre-







 The statistical analysis was composed of a descriptive, a two-way test of association, 
followed by multivariate logistic regression to address Research Question 1, and logistic 
regression to address Research Question 2.  Categorical variables were analyzed to determine the 
percentage of male and female subjects as well as to define race/ethnicity in each category.  
Further analysis assisted in defining the number of subjects by medical comorbidity and year.  
The mean, mode, and standard deviation were calculated per category to exhibit variations per 
year.  The research analyses likewise assisted in establishing a high or low rate of 
reimbursement, and determining the average LOS for Medicare patients with hypertensions.  The 
covariates were analyzed to determine the significance in variations. 
Power Analysis 
     
 
Sample Size: X-Sectional, Cohort, & Randomized Clinical Trials 
Two-sided significance level(1-alpha): 95  
Power(1-beta, % chance of detecting): 80  
Ratio of sample size, Unexposed/Exposed: 3  
Percent of Unexposed with Outcome: 50  
Percent of Exposed with Outcome: 67  
Odds Ratio: 2  
Risk/Prevalence Ratio: 1.3  
Risk/Prevalence difference: 17  
 
 Kelsey Fleiss Fleiss with CC  
 
Sample Size - Exposed 94 92 100  
Sample Size-Nonexposed 281 275 298  
 




Kelsey et al., Methods in Observational Epidemiology 2nd Edition, Table 12-15 
Fleiss, Statistical Methods for Rates and Proportions, formulas 3.18 &3.19 
CC = continuity correction 
Results are rounded up to the nearest integer. 





 The power analysis was calculated with the utilization of Open Source Epidemiologic 
Statistics for Public Health, Version 2.3.1 (Open Source Epidemiologic Statistic for Public 
Health, 2013).  The power analysis calculations for sample size yielded a minimum of 398 for 
the research study, given a beta of 80% which provided a high enough effect volume for 
determining the LOS and reimbursement rate for Medicare patients with hypertension.  The 
estimated confidence level, power, odds ratio, ratio of unexposed to exposed, and percentage of 
unexposed with outcome were calculated to assist in determining an effective sample size for the 
research study by utilizing the sample cohort and randomized clinical trial study calculations 
provided by Open Source Epidemiologic Statistics for Public Health. 
Instruments and Materials 
 The Healthcare Cost and Utilization Project (HCUP) nationwide database of the National 
Inpatient Sample (NIS) database that encompassed a secondary dataset from 2011 to 2013 was 
utilized.  The secondary dataset encompassed patients as the unit of analysis, and provided data 
for the dependent and independent variables that were analyzed.  SPSS was the statistical tool 
utilized to measure the data by applying a logistic regression analysis.  Upon receiving 
calculations post logistic regression analysis and descriptive statistic assisted in analyzing the 
data within SPSS, and interpretation aided in determining a null or alternative hypothesis. 
The dependent variable, LOS was analyzed in conjunction with the independent variable 
of reimbursement rate.  The covariates within the research were age, gender, location, timeframe 
in which services were rendered ethnicity/race, and diabetes.  The location of the research was 
limited to United States, and the ethnicities represented included White, Asian/Pacific Islander, 
Black/African-American, Hispanic, and other to encompass smaller groups.  The timeframe for 





the gap in literature as well as current and past findings pertaining to the LOS.  The secondary 
dataset was tested against the following research study questions:  
RQ1 – Are reimbursement rates related to the LOS for Medicare patients with hypertension as 
the reason for admission after controlling for state, age, year, gender race/ethnicity, and diabetes? 
H1: The hospital reimbursement rate is related to the LOS for Medicare patients with 
hypertension as the reason for admission when controlling for state, age, year, gender, 
race/ethnicity, and diabetes. 
H2:  The hospital reimbursement rate is not related to the LOS for Medicare patients with 
hypertension as the reason for admission when controlling for state, age, year, gender, 
race/ethnicity, and diabetes. 
RQ2 – Are the hospital reimbursement rates associated with prolonged hospitalization for 
Medicare patients admitted for hypertension when controlling for state, age, year, gender, 
race/ethnicity, and diabetes? 
H3:  The hospital reimbursement rate is associated with prolonged hospitalization for Medicare 
patients with hypertension as the reason for admission when controlling for state, age, year, 
gender, race/ethnicity, and diabetes. 
H4:  The hospital reimbursement rate is associated with prolonged hospitalization for Medicare 
patients with hypertension as the reason for admission when controlling for state, age, year, 
gender, race/ethnicity, and diabetes. 
Data Protection and Privacy  
 The research study underwent the approval process of the Walden University Institutional 
Review Board (IRB) to utilize an external secondary dataset.  The Data Protection Act 1998 was 





Protection Commission, 2017).  This act protects individuals from being exploited and private 
information from unsolicited distribution.  This data protection act was also applied to ensure 
that Protected Health Information (PHI) was safeguarded and provided individuals with an array 
of privacy rights.  The PHI rights however permit the disclosure of data required for quality of 
patient of care and necessary documentation for verification.  PHI also works in conjunction with 
the Health Insurance Portability and Accountability Act (HIPAA) to ensure patient 
confidentiality in relation to electronic or hardcopy data within research studies as well as in 
healthcare facilities. 
The protection of human subjects during the course of research required permission for 
academic institutions and clinical trials.  All patient specific information was protected and 
underwent re-coding where necessary to uphold patient privacy during the duration of the 
research study.  Approval from Walden IRB and HCUP privacy agreement use sustained and 
presented no harm to the individual information provided by HCUP participants.  The research 
did not present any ethical issues for the university, Medicare, the researcher, or participants in 
an effort to further determine gaps in previous related literature.  
Threats to Validity 
 A critical threat to validity of the research study that had implications was the 
misdiagnosis of hypertension for Medicare beneficiaries who were pre-hypertensive and those 
who had infrequent occurrences of elevated blood pressure.  The volume of patients who had a 
prevalence of hypertension and had been medically diagnosed for a period of greater than 6 
months provided more reliable data than beneficiaries who had elevated blood pressure readings 
caused by stress, diet, exercise, or additional factors.  An external factor that may have impacted 





physically disabled, and were diagnosed as hypertensive.  To safeguard against threats to 
statistical validity, data representing a period of 4 years were utilized to permit a larger sample 
size as well as the ability to exhibit possible variations within a given timeframe. 
Summary 
 In summary, the quantitative research study was conducted to determine whether there 
was a correlation between LOS and reimbursement rates for Medicare patients with 
hypertension.  The (HCUP) Nationwide database of the National Inpatient Sample (NIS) was 
utilized as the secondary source for data.  The secondary data source was converted to SPSS 
which assisted in further analyzing the dependent and independent variables as well as applicable 
covariates associated with the research study.  The variables applied with the research were 
relevant to place, time frame, and patient.  The sample size of 398 for the time frame of 2011 to 
2013 was calculated as a sufficient size to ensure and effective population size.  The target 
population for the research study was Medicare patients that were medically diagnosed with 
hypertension within the United States. This size was determined by the calculations provided by 













Section 3:  Research Results 
Introduction 
 The objective of the research study was to determine whether there was a correlation 
between the LOS and the rate of reimbursement among Medicare recipients with hypertension 
while controlling for multiple covariates as listed in the research questions below.  
RQ1 – Are reimbursement rates related to the LOS for Medicare patients with hypertension as 
the reason for admission after controlling for geographic region, age, year, gender race/ethnicity, 
and diabetes? 
H1: The hospital reimbursement rate is related to the LOS for Medicare patients with 
hypertension as the reason for admission when controlling for geographic region, age, year, 
gender, race/ethnicity, and diabetes. 
H2:  The hospital reimbursement rate is not related to the LOS for Medicare patients with 
hypertension as the reason for admission when controlling for geographic region, age, year, 
gender, race/ethnicity, and diabetes. 
RQ2 – Are the hospital reimbursement rates associated with prolonged hospitalization for 
Medicare patients admitted for hypertension when controlling for geographic region, age, year, 
gender, race/ethnicity, and diabetes? 
H3:  The hospital reimbursement rate is associated with prolonged hospitalization for Medicare 
patients with hypertension as the reason for admission when controlling for geographic region, 
age, year, gender, race/ethnicity, and diabetes. 
H4:  The hospital reimbursement rate is not associated with prolonged hospitalization for 
Medicare patients with hypertension as the reason for admission when controlling for geographic 





Data Cleaning and Preprocessing 
 The initial sample size for the secondary data set was comprised of 22,440,121 cases for 
three consecutive years (2011, 2012 & 2013) across the United States. The data set was filtered 
by inclusion of the hypertensive Medicaid patients and further randomized to consist of 3,000 
cases.  The randomized results entailed a total of 197 missing cases for race/ethnicity.  The 197 
cases within the data set may have been attributed to patients having the option of not completing 
documentation for race/ethnicity, or refusing to provide race/ethnicity information when 
Medicaid status was provided.  The exclusion of 197 cases of the 3,000 produced a 6.6% 
omission factor for the cases to be analyzed, thus creating a very minimal impact.  An additional 
inclusion criterion was applied whereby patients needed to be a minimum of 18 years of age 
because the research study was geared toward an aging population.  Recoding for all variables 
was utilized to formulate data with numeric measures for precise analysis. 
Descriptive Statistics 
 The below table represents the descriptive statistical data output for the research study 
utilizing the results for (N = 3,000) cases.  The analysis encompassed the dependent variable of 
LOS and the independent variable rate of reimbursement along with covariates that consisted of 
age, gender, race/ethnicity, rate of reimbursement, year, region of the United States, and 
diabetes.  The dependent variable of LOS was divided into two categories of short duration and 
long duration of hospital stay. The dependent variable of LOS was a dichotomous measure that 
contained short and long hospitalization.  The population of the research study encompassed 
individuals with Medicare over the age of 18 who had been medically diagnosed as hypertensive.  
Medicare patients who were not classified as physically handicapped or under the age of 18 were 







Summary of Descriptive Statistics of LOS, Age, Gender, Reimbursement Rate, Race/Ethnicity, 
Region, Diabetic, and Year for Medicare patients. 
Variable        Characteristic                                 N = 3,000                               Percentage 
 
LOS                         0-3 days       1543           51.4% 
           >=4 days      1457         48.6% 
Age          18-65       1277                    42.6%  
          66-85       1299         43.3%   
                                 >= 86         424         14.1%  
Rate of                     0 -25%        755         25.2%  
Reimbursement       26-50%        732         24.4%  
          51-75%        734         24.5%  
                                76-100%        779         26.0%  
Gender                    Female                                           1386         46.2% 
                                Male       1614         53.8% 
Race/Ethnicity        White       1998         71.3% 
                                Black         438         15.6%      
                                Hispanic         221          7.9% 
                                Asian           53          1.9%  
                                Other           93          3.3%  
Region                     South         430         14.3% 
                                Northeast         697         23.2%  
                                Mid-West      1676   `      55.9%   
                      West         197           6.6%  
Diabetic                  Yes       2128        70.9%   
          No         872        29.1%  
Year          2011       1371        45.7%  
          2012       1186        39.5%  
          2013         443        14.8%  
Note:  The data output for descriptive statistical analysis utilizing a sample size of 3,000 cases  









As show in the above descriptive table reflected 3 consecutive years, the data represents 
the results of descriptive statistics (N = 3000).  The dependent variable LOS was grouped into 
two classifications of 0-3 days, and greater than or equal to 4 days.  Approximately 51.4% (N = 
1543) were hospitalized for 0-3 days, and 48.6% (N = 1457) hospitalized for 4 days or greater 
over a three-year consecutive time frame.  The variable age of Medicare patient was categorized 
into three classifications that were 18-65 years included 42.36% (N = 1277) ; 66-85 years 
included 43.3% (N = 1299); and greater than or equal to 86 years of age at 14.1% (N = 424).   
The rate of reimbursement was categorized in 4 groups which consisted for low rate of 
reimbursement 0-25%, moderately low 26-50%, moderately high 51-75%, and high rate of 
reimbursement which consisted of 76-100% compensation. The low category of rate of 
reimbursement applied to 25.2% of the participants (N = 755), the moderately low category 
accounted for 24.4% (N = 732), moderately high applied to 24.5% (N = 734), and the high rate of 
reimbursement applied to 26.0% (N = 779).  Although rate of reimbursement appeared consistent 
in calculations, the high rate of reimbursement was analyzed to be higher than the other three 
categories. 
 Data for the variable gender indicated that females were represented at 46.2% of the 
sample (N = 1386), while males represented a slightly higher percentage 53% (N = 1614).  Data 
for the variable race/ethnicity was classified into five groups.  The variable ethnicity indicated 
that 71.3% (N = 1998) were White; 15.6% (N = 438) were Black; 7.9% (N = 221) were Hispanic, 
1.9% (N = 53) were Asian; and 14.3% (N = 93) were classified as other or missing 
race/ethnicity.   Region was categorized into four groups across the United States:  South, 





sample; Northeastern accounted for 23.2% (N = 697); Mid-Western accounted for 55.9% (N = 
1676); and Western United States represented 6.6% (N = 197).  
 The research study also included the comorbidity of diabetes which accounted for 70.9% 
(N = 2128) of which were diabetic, and 29.1% (N = 872) of the Medicare patients that were 
hypertensive but not diabetic and hypertensive. The research study encompassed three 
consecutive years of 2011, 2012, and 2013.  In 2011 there were 45.7% (N = 1371) cases, in 2012 
39.5% (N = 1186), and 2013 accounted for 14.8% (N = 443) 
Two Way Tests of Association 
Table 6 
Summary of Two-Way Tests of Association Among LOS and Independent Variables 
                          LOS          P- 
Variable   Category       0-3 Days      >=4 Days      value           Total 
 
Age         18-65  Count   719  558         1277  
    % with Age  56.3%  43.7%         100% 
    % with LOS  46.6%  38.3%   42.6%  
 
     66-85      Count   625  674      .000 1299 
    % with Age  48.1%  51.9%   100% 
    % with LOS  40.5%  46.3%   43.3%  
 
               >=86   Count   199  225       .001           424 
    % with Age  46.9%  53.1%   100% 
    % with LOS  12.9%  15.4%   14.1% 
 
Total    Count   1543  1457   3000 
    %with Age  51.4%  48.6%   100% 
    % with LOS  100%  100%   100% 









                                       LOS            P- 
Variable     Category     0-3 Days      >=4 Days      Value    Total 
Rate of         0-25%  Count   602  153       .000 755 
Reimbursement  % with ROR  79.7%  20.3%   100% 
    % with LOS  39.0%  10.5%   25.2% 
 
         26-50%  Count   436  296            .000 732 
    % with ROR  59.6%  40.4%   100% 
    % with LOS  28.3%  20.3%   25.2% 
 
        51-75%  Count   306  428       .000 734 
    % with ROR  41.7%  58.3%   100% 
    % with LOS  19.8%  29.4%   24.5% 
 
        76-100%  Count   199  580         779 
    % with ROR  25.5%  74.5%   100% 
    % with LOS  12.9%  39.8%   26.0%  
 
Total    Count   1543  1457   3000 
    % with ROR  51.4%  48.6%   100% 
    % with LOS  100%  100%   100% 
   
Gender        Male  Count   822  792   1614 
    % with Male  50.9%  49.1%   100% 
    % with LOS  53.3%  54.4%   53.8% 
 
          Female  Count   721  665      .298 1386 
    % with Female 52.0%  48.0%   100% 
    % with LOS  46.7%  45.6%   46.2% 
 
Total    Count   1543  1457   3000 
    % with Gender 51.4%  48.6%   100% 
    % with LOS  100%  100%   100% 











                                       LOS            P- 
Variable        Category    0-3 Days      >=4 Days      Value    Total 
Race/  White  Count   1018   980   1998 
Ethnicity   % with LOS  71.2%  71.3%   71.3% 
    % with Race  51.0%  49.0%   100% 
 
  Black  Count   220  218        .965 438 
    % with LOS  15.4%  15.9%               15.6% 
    % with Race  50.2%  49.8%   100% 
  
  Hispanic Count   124  97        .543 221 
    % with LOS  8.7%  7.1%   7.9%  
    % with Race  56.1%  43.9%   100% 
   
  Asian  Count   27  26        .502 53  
    % with LOS  1.9%  1.9%   1.9% 
    % with Race  50.9%  49.1%   100% 
  
  Other  Count   40  53       .926 93  
    % with LOS  2.8%  3.9%   3.3%  
    % with Race  43.0%  57.0%   100% 
 
Total    Count   1429  1374   2803 
    % with LOS  100%  100%   100% 
    % with Race  51.0%  49.0%   100% 
 
Year  2011  Count   691  680   1371 
    % with LOS  44.8%  46.7%   45.7% 
    % with Year  50.4%  49.6%   100% 
 
  2012  Count   626  560      .254 1186 
    % with LOS  40.6%  38.4%   39.5% 
    % with Year  52.8%  47.2%   100% 
 
  2013  Count   226  217      .025 443 
    % with LOS  14.6%  14.9%   14.8% 
    % with Year  51.0%  49.0%   100% 
 
Total    Count   1543  1457   3000 
    % with LOS  100%  100%   100% 








                                       LOS           P- 
Variable        Category    0-3 Days      >=4 Days      Value       Total 
Region South  Count   214  216   430 
    % with LOS  13.9%  14.8%   14.3% 
    % with Region 49.8%  50.2%   100% 
 
  Northeast Count   351  346       .864 697 
    % with LOS  22.7%  23.7%   23.2% 
    % with Region 50.4%  49.6%   100% 
 
  Mid-West Count   928  748        .022 1676 
    % with LOS  60.1%  51.3%   55.9% 
    % with Region 55.4%  44.6%   100% 
 
  West  Count   50  147             .002 197  
    % with LOS  3.2%  10.1%   6.6% 
    % with Region 25.4%  48.6%   100% 
 
Total    Count   1543  1457   3000 
    % with LOS  100%  100%   100% 
    % with Region 51.4%  48.6%   100% 
 
 
Diabetic Yes  Count   1106  1022        .355 2128 
    % with LOS  71.7%  70.1%   70.9% 
    % with Diabetes 52.0%  48.0%   100% 
 
  No  Count   437  435   872 
    % with LOS  28.3%  29.9%   29.1% 
    % with Diabetes 50.1%  49.9%   100% 
    
Total    Count   1543  1457   3000 
    % with LOS  100%  100%   100% 












 Table 6 represents the results of the two-way test of association among each independent 
variable and the dependent variable LOS for short and long duration.  Table 6 also displays the 
p-value for each independent variable which serves as the indicator of the variable being 
statistically significant or not statistically significant. The two-way tests encompassed a sample 
size of (N = 3000) cases.  The age category of 18-65 years had a short stay of 40.5% (N = 625) 
and a long duration of 46.3% (N = 674) which yielded (p = .000) indicating that the variable was 
statistically significant.  The age range of 66-85 years had 46.6% (N = 719) of the highest 
percentage in short duration of hospitalization among all age categories.  The age category of 
>=86 years yielded the lowest in short duration with 12.9% (N = 199) as well as long duration 
with 14.1% (N = 424). 
 The rate of reimbursement, 0-25% chance of being reimbursed yielded the second highest 
number of cases at 39% (N = 602).  It also yielded a percentage in long duration category was 
lower for patients with low reimbursement rate at 10.5% (N = 153).  The highest rate of 
reimbursement in the category of 76-100% yielded at 39.8% (N = 580) rate of reimbursement. 
The category of 26-50% yielded 28.3% (N = 436) short duration and 51-75% produced 29.4% (N 
= 428) for long duration.  These results yielded a statistically significant (p-value = .000) 
independent variable for the entire category. 
 The variable gender had two categories, female and male with a higher rate for both short 
and long duration for males.  The short duration for males was analyzed at 53.3% (N = 822), 
with 54.4% (N = 792) for long duration. Females yielded 46.7% (N = 721) for short duration and 
45.6% (N = 665) for long duration, producing a (p-value = .298) and indicating a variable that 





 The race/ethnicity variable was not statistically significant in no categories due to each p-
value being greater than .05.  The white category had a considerable margin over the other races 
at 71.2% (N = 1018) for short duration and 71.3% (N= 980) for long duration.  The black 
category for short duration was 15.4% (N = 220) and 15.9% (N = 218) for long duration. The 
other races classified as Hispanic, Asian, and other were all less than 9% for both short and long 
duration of hospital stay.  The variable region was categorized into 4 groups that span across the 
United States.  South, Northeast, Mid-West, and West regions were all analyzed for short and 
long duration which yielded a considerable difference among the Mid-West region at 60% (N = 
928) for short duration and 51.3% (N = 748) for long duration.  The Western region was at a 
mere 3.2% (N = 50) for short duration and 10.1% (N = 147) for long duration making it the 
lowest in both categories nationwide.  These results yielded the Mid-West and West statically 
significant with a (p-value = .022 and p-value = .002). 
 The diabetic variable generated 71.7% (N= 1106) for short duration and 70% (N = 1022) 
for long duration indicating that approximately 72% of hypertensive Medicare patients were also 
diabetic.   While 28% (N = 437) short duration patients and 29.9% (N = 435) long duration 
patients were not diabetic; however, hypertensive.  The diabetic variable was not statistically 
significant with a (p-value = .355).  The calendar year variable of  2011 and  2012 yielded a 
variable that was not statistically significant.  The year 2011 yielded a 44.8% (N = 691) for short 
duration and 46.7% (N = 680) for long duration placing it at the highest rate of hospital stay in 
both categories during 2011.  The year 2012 yielded results of 40.6% (N = 626) for short 
duration and 38.4% (N = 560) for long duration ranking 2012 as the median for LOS for both 





duration with a 14.6% (N = 226) for short duration and 15% (N = 217) for long duration of 
hospitalization being statistical significance (p-value = .025). 
 
Multiple Logistic Regression Analysis 
Table 7 
Multiple Logistic Regression Analysis of Short Duration LOS and Long Duration LOS  
(N = 3000) 
Variable        Characteristic          Adjusted Odds 95% C.I.  P-Value 
                                                Ratio 
Age          18-65       Reference                 
          66-85           .724             .604 - .868                 .000        
                                 >= 86         1.547            1.195 -  2.003              .001   
Rate of                     0 -25%           .081             .063 - .105   .000        
Reimbursement       26-50%           .236             .187 - .298                    .000 
          51-75%           .475             .377 - .599                    .000 
                                76-100%        Reference 
Gender                    Female                         .915                     .744 - 1.081            .298  
                     Male       Reference       
Race/Ethnicity        White       Reference                       
Black          1.221              .965 - 1.545     .097           
Hispanic            .740              .543 - 1.008                 .056 
                                Asian            .923   .502 - 1.695                 .795 
                                Other          1.495          .926 - 2.412                1.000 
Region                     South      Reference                                 
                                Northeast           1.025               .724 - 1.357                 .864 
                                Mid-West            .707         .525 -   .952                 .022 
                      West           2.026         1.300 - 3.157                 .002 
Diabetic                  Yes     Reference               
          No           1.182       .985 - 1.419                  .072 
Year          2011     Reference               
          2012          1.141               .910 – 1.431                 .254 









 Table 7 represents a multiple logistic regression model of the cases (N = 3000) which 
illustrated the odds ratio, 95% confidence interval, and p-value.  A multiple logistic regression 
analysis was conducted to establish the correlation between dependent variable and the 
independent variables while controlling for the covariates.  The multiple logistic regression also 
ascertained the presence of probability of the given output with specific percent.  The dependent 
variable LOS was dichotomous for short duration (recoded = 0) or long duration of stay (recoded 
= 1).  The following variables were not statistically significant:  gender, year (2012), 
race/ethnicity, region (northeast and south), and diabetes.  The statistically significant variables 
were age, rate of reimbursement, region (Mid-West, West), and the year (2013). 
The variable age had a reference category of 18-65 years old that was primarily utilized 
as a reference group due to a healthier age range of Medicare patients.  The adjusted odds ratio in 
66-85 years was .724 (p-value = .000) and (95% confidence interval range of .604 - .868), 
yielding a statistically significant age category.  The age range of 66-85 had an odds ratio of a 
long stay which were lower for this age group compared to reference category. The age category 
ranging >= 86 years had an adjusted odds ratio of 1.547 (p-value = .001) and  (95% confidence 
interval range of 1.195 – 2.003).  This category age range was also statistically significant due to 
the p-value and with a provided 1.547 chance more likely to have an extended hospitalization 
than the reference group. 
The reference group of 75-100 percentile was utilized for the rate of reimbursement.  The 
category of 0-25% yielded an adjusted odds ratio of .081 and (95% confidence interval range of 
.063 - .105), making this category 91.9% lower odds of having a longer LOS than the highest 





confidence interval range of .377 - .599), making this category 52.5% lower odds of having a 
longer LOS than the reference group.   
The variable region was statistically significant in the Mid-West and West regions.  The 
Mid-West region was statistically significant with a (p-value = .022) with an adjusted odds ratio 
of .707 and (95% confidence interval of range of .525 - .952).  The West region was statistically 
significant with a (p-value = .002) and an adjusted odds ratio of 2.026 which presented greater 
significance as compared with the reference group.  
The variable year utilized 2011 as the reference group since it had the largest frequency 
of (N = 1242). The variable year of 2013 generated an adjusted odds ratio of 1.403 (95% 
confidence interval range of 1.044 – 1.885) with a statistically significant (p-value = .025), 
yielding a greater significance as compared to the reference group. The year 2012 was not 
statistically significant with a (p-value = .254).  The adjusted odds ratio was 1.403 (95% 
confidence interval range of .910 – 1.431), yielding a category with greater significance as 
compared to the reference group. 
Summary 
 The purpose of the descriptive analysis was to summarize the variables and 
measurements within the research study with the use of quantitative analysis.  The two-way test 
of association was conducted to determine the relationship between the dependent and 
independent variable.  The objective of the multivariate logistic regression was to establish 
which variables impacted to the LOS and determine the odds ratio, 95% confidence interval, and 
the statistical significance of each variable.  The age group with the largest ratio belonged to the 
66-85 years old at 41% (N = 1216).  The rate of reimbursement variable yielded consistency in 





= 700) among the 4 groups.  The 95% confidence interval for the rate of reimbursement ranged 
from (.063 to .599) for 3 categories and a (p-value = .000) for each category with the adjusted 
odds ratio ranging (.081 to .475) as compared to the reference group. 
Although gender was not statistically significant, the gender variable female had slightly 
under 46.2% (N = 1386) with a .915% adjusted odds ratio compared to males.  Females were 
8.5% less likely to have longer hospitalization compared to the reference group.  While the white 
race/ethnicity had the bulk of cases as white with a frequency of 67% (N=1998), the 
race/ethnicity variable did not have any statistically significant categories. 
Only the Mid-West and Western regions had a statistical significance (p-value =.002 and 
p-value = .022) in each region that may be attributed to geographic variation with in rural areas, 
and in unplanned hospital admission rates.  The odds ratio of the Mid-West region yielded .707 
(95% confidence interval range of .525 - .952), producing a 29.3% lower odds of having a longer 
LOS than the reference group.  The West region yielded a 2.026 adjusted odds ratio with (95% 
confidence interval range of 1.300 – 3.157), which produced greater significance as compared 
with the reference group.  
The comorbidity of diabetes did not have statistical significance or impact on the 
correlation of LOS and the rate of reimbursement.  The year variable presented significance in 
2013 which yielded a (p-value = .025).  Despite the multiple variables presented, none of the 
variables eliminated the correlation between LOS and rate of reimbursement.  Section 4 presents 
the interpretation of findings, research study discussion, social change, and suggestions for 
additional research. 
The below first research question cannot be resolved due to the dependent variable LOS 





question cannot be addressed due to the omission of a continuous LOS, a rejection or acceptance 
of null or alternative hypothesis cannot be applied; therefore, the research question was removed. 
RQ1 – Are reimbursement rates related to the LOS for Medicare patients with hypertension as 
the reason for admission after controlling for geographic region, age, year, gender race/ethnicity, 
and diabetes? 
H1: The hospital reimbursement rate is related to the LOS for Medicare patients with 
hypertension as the reason for admission when controlling for geographic region, age, year, 
gender, race/ethnicity, and diabetes. 
H2:  The hospital reimbursement rate is not related to the LOS for Medicare patients with 
hypertension as the reason for admission when controlling for geographic region, age, year, 
gender, race/ethnicity, and diabetes. 
Research question two direct variable LOS is categorical and significant; therefore, the 
null hypothesis was rejected and the alternative hypothesis was accepted.  The (p-value = .000) 
presented significance between the dependent (LOS) and independent variable (rate of 
reimbursement). 
RQ2 – Are the hospital reimbursement rates associated with prolonged hospitalization for 
Medicare patients admitted for hypertension when controlling for geographic region, age, year, 
gender, race/ethnicity, and diabetes? 
H3:  The hospital reimbursement rate is associated with prolonged hospitalization for Medicare 
patients with hypertension as the reason for admission when controlling for geographic region, 





H4:  The hospital reimbursement rate is not associated with prolonged hospitalization for 
Medicare patients with hypertension as the reason for admission when controlling for geographic 

























Section 4:  Discussion, Conclusion, and Recommendations 
Overview 
 The purpose of this research study was to examine variations in LOS for Medicare 
patients with hypertension and to provide an analytical explanation for the risk factors that have 
been driving Medicare patients’ extended stay.  The objective was also to explain the logic 
behind costs applied for the duration of hospitalization and grasp concepts relevant to 
standardizing reimbursement rates for Medicare recipients without placing limitations on 
patients’ extended stay.  The research involved further examination of cost-shift theory in 
relation to Medicare reimbursement while simultaneously assisting in determining the variations 
in current Medicare payment policies by state. 
Interpretation of Findings 
 The quantitative outcome of the research study revealed that the statistically significant 
variables were age, rate of reimbursement, region (Mid-West and West), and calendar year 2013.   
The age category of 65-85 years displayed a greater odds ratio than the reference group which 
was further explained by the onset age of 65 years for Medicare patients.  Although, typically 
people within the age range of 18-65 years may display a healthier population than the aging 
patients from 65-85 years, extended stay rates for the latter were lower than the reference group.  
The rate of reimbursement reference category of 0-25 percentile for 0-3 days had the greatest 
amount of cases (N=602), however, the highest percentage of LOS was 39.8% in the >= 4 days 
category.  The category with the lowest percentage of extended stay was in the 0-25 percentile 
with a 10.5% hospitalization, and a 20.3% rate of reimbursement for >= 4 days duration.  The 
rate of reimbursement was the highest in the 0-25 percentile at 79.7% which indicated that only a 
quarter of reimbursements were paid by Medicare at nearly an 80% probability for the Medicare 





compensation for short duration, only 25.5% are reimbursed; however, the >= 4 days category 
for the 75 -100th percentile displayed 74.5%, which indicated that the rate of reimbursement for 
longer duration had a greater probability of reimbursement. 
 The variable of region encompassed two categories that were statistically significant.  
The Mid-West region contained the highest number of cases (N = 928) with a 60.1% LOS for 0-3 
days duration.  The >= 4 days category was comprised of 51.3% extended say which yielded the 
longest duration in all regions.  The West region yielded the lowest number of cases (N= 50) in 
all regions with a 3.2% LOS for the 0-3 days category.  The West region also consisted of the 
longest extended stay within the region for the >= 4 days category at74.6%.  The outcome for the 
Mid-West and West regions may primarily be due to the geographic adjustment variations that 
occur within regions that are not as densely populated.  The results for the regions elucidated that 
there are geographic variations among more rural states that permit a higher rate of 
reimbursement as well as an extended length of hospitalization among Medicare hypertensive 
patients.   
 The variable of year contained three categories, of which only 2013 was statistically 
significant.  The 0-3 days was comprised of (N = 226), which was nearly 15% of the total 
population for the short duration.  The extended stay for the 0-3 days category was 14.6% of (N 
= 1543) for short duration, which was significantly lower than both 2011 and 2012 (44.8% & 
40.6%).  The >= 4 days category in 2013 yielded 14.8% of the (N = 1457) for percentage of 
extended stay for long duration.  Both short and long duration for the calendar year 2013 yielded 
a total of (N = 443) cases out of the (N = 3000) at a 14.8% total LOS.  The calendar year 2013 
had the lowest amount of cases which can be attributed to the number of Medicare patients 





 The variables such as race/ethnicity, gender, and diabetes were discovered to have no 
impact on the rate of reimbursement or LOS for Medicare patients with hypertension as well as 
no statistical significance.  The findings of the research assisted in identifying gaps in the 
literature concerning which factors impacted the rate of reimbursement and the LOS.  
Geographic adjustment variations within the Mid-West and West regions played a significant 
role in fluctuations among the dependent and independent variables; however, the correlation 
between LOS and rate of reimbursement remained consistent despite the covariates that were 
applied. 
 The significance of the research study provided an analytical explanation of the risk 
factors that drive the rate of reimbursement and the LOS for Medicare patients with hypertension 
by exposing variations such as geographic adjustments.  The significance of the research study 
also contributed a new viewpoint to previous and forthcoming research studies resources that 
focus on Medicare patients’ hospital duration and the influence it has on Medicare’s rate of 
reimbursement across each region of the United States.  The findings of the research study also 
integrated the literature review by further emphasizing the variations in reimbursement and 
hospital duration for Medicare hypertensive patients as displayed in the analysis.  Likewise, the 
research study revealed the determinants of extended stay, and the influence on reimbursement 
rates across four regions in the United States that were presented in the analysis.  As in previous 
research studies, the literature review incorporated extended hospitalization and rate of 
reimbursement to have variations across different regions.  More specifically, the Mid-West and 
West regions exhibited the greatest variations as compared to the other regions.  This was 
primarily due to the geographic adjustment variations within rural regions that are customary for 





 The epidemiological triad model that was utilized was deemed necessary, in that it 
provided a critical aspect of encompassing Medicare patients across the United States within the 
timeframe of 2011 to 2013.  The epidemiological framework was utilized to investigate 
Medicare hypertensive patients and hospital outcomes in relation to rates of reimbursement.  
More specifically, person was represented by Medicare patients, place was identified as 4 
regions within the United States, and time was exhibited by the years 2011 to 2013.  The triad 
model implemented the LOS, person, place, and time frame for an effective approach illustrating 
the interaction among the factors within the model.  The conceptual framework directed 
epidemiological exploration of variations in lengths of stay.   
 The research study and existing research studies were synthesized by exploring various 
factors such as race, region, gender, age, comorbidities, Medicare reimbursement rates, and 
yearly time frame to determine prolonged hospitalization for hypertensive Medicare patients.  
The research correlation also sought out the national LOS and modifications that occurred with 
the rate of reimbursement, and the analysis revealed that patients who were admitted typically 
stayed 0-3 days unless multiple comorbidities were present.  Medicare patients who were 
hospitalized for >= 4 days displayed hypertension and additional health conditions such as 
diabetes, renal failure, and congestive heart failure which were commonalities among 
hypertensive patients.  The research studies provided a response to an identified issue with 
variations in Medicare reimbursement and LOS variations within the United States.  This 
research study has addressed where (Mid-West & West), what (geographic adjustments factors), 
and why (estimations of operating expenses in rural regions) questions pertaining to variations in 
reimbursement rates occur for hypertensive Medicare patients.   The factors that were once 





Limitations of the Study 
 The limitations of the research included of omission of the dependent variable LOS not 
having a continuous measure within the secondary data set.  The secondary data set only 
provided the dependent variable LOS to be analyzed as categorical, with the categories 0-3 days 
and >= 4 days. Due to the omission of a continuous dependent variable, the below Research 
Question 1 was not answered, and the researcher could not reject or accept the hypothesis or null 
hypotheses. Therefore, the first research question could not be analyzed, and only leaving the 
second research question to be analyzed and  to address the significance of the research and 
hypothesis.   
RQ1 – Are reimbursement rates related to the LOS for Medicare patients with hypertension as 
the reason for admission after controlling for geographic region, age, year, gender race/ethnicity, 
and diabetes? 
H1: The hospital reimbursement rate is related to the LOS for Medicare patients with 
hypertension as the reason for admission when controlling for geographic region, age, year, 
gender, race/ethnicity, and diabetes. 
H2:  The hospital reimbursement rate is not related to the LOS for Medicare patients with 
hypertension as the reason for admission when controlling for geographic region, age, year, 
gender, race/ethnicity, and diabetes. 
 Prior to the analysis of the secondary dataset, it was unknown that secondary data set 
would have excluded a continuous direct variable prior to analyzing the data set.  The unknown 
factor was uncovered during the analysis and could not have been foreseen prior to internal 
review board (IRB) approval.  This exclusion impacted the research by reducing necessary 





patients with hypertension as the reason for admission after controlling for geographic region, 
age, year, gender race/ethnicity, and diabetes. 
Recommendations for Further Research 
 Further research could also encompass the mortality rate of hypertensive Medicare 
patients.  Hypertension-related mortality increased by 23% overall from 2000-2013 for both men 
and women (Centers for Disease Control and Prevention, 2015).  The mortality rate for men 
within the age range of 45-64 years old displayed a 58.2% increase and 65-74 years exhibited a 
16.5% increase with a statistically significant (p-value = .05).   The mortality rate can be 
incorporated within the existing covariates or perhaps replace covariates that were not 
statistically significant within the research study. 
 An additional recommendation for further research would require isolation of geographic 
regions to provide explicit populations from specific states and contrast the variations among an 
itemized number of states.  Identifying exact states may provide a researcher with the capability 
to compare particular states that utilize geographic adjustments in rates of reimbursements as 
well as target the number of days that hypertensive Medicare patients are being allotted for 
hospitalization.  State isolation would also permit a researcher to associate variations in Medicare 
policies per state by examining differences in adjustments per region and state. 
 Geographic adjustments in Medicare reimbursement have been utilized within regions in 
an effort to ensure that medical providers within rural areas are being fairly compensated 
based on operating expenses within the region and state.  By incorporating a more specific area 
for analysis would also permit for a researcher to further examine reimbursement rates that 
typically result in over or under payment for Medicare expenses.  Future research could also 
integrate variables such as primary payer, secondary insurance type, Medicare DRG coding, total 





Implication for Social Change 
Implications for social change may deliver a foundation for policy reform by furnishing 
analyzed data to Medicare and policy decision-makers to amend guidelines for reimbursement 
rates and LOS.  The social change could be methodologically significant because it may assist in 
employing utilization of current ICD-10 codes, and this; may result in higher accuracy of 
medical diagnosis than was seen prior to ICD-10.  The research may assist in social change by 
providing explanation for trends in Medicare lengths of stay.  Likewise, the study may assist 
healthcare administrators in standardizing reimbursement rates for Medicare recipients without 
placing limitations on the patients’ LOS, and possibly improving patient outcomes.   
The research may also be significant for social change because it could provide further 
insight into the cost-shift theory for Medicare reimbursement while simultaneously assisting in 
determining variations in current Medicare payment policies.  These policies contain incentives 
for healthcare to optimize reimbursement that may lead to efficient lengths of stay for Medicare 
recipients.   The implications could include unearthing the logic behind particular Medicare 
states refusing to cover extended LOS, while LOS and reimbursement rates in other states 
exhibit dramatic dissimilarities.  The social change has the capability to be meaningful due to the 
potential to reveal rationale for a government entity not being transparent across the board, as 
well as to indicate whether there has been any improvement to decrease the fluctuations. 
Furthermore, the research study may have implications for social change in that it may 
lead to an even distribution of reimbursements which may alleviate medical and financial strain 
on Medicare patients and their families.   Medicare patients who reside in densely populated 







 In summation, the research provides insight on rates of reimbursement across 4 regions, 
indicating that the Mid-West and West regions of the United States utilizing geographic 
adjustment variations.  The adjustment variations have modified the rate of reimbursement as 
well as the length of hospitalization in these two regions.  Although, there is prevalence of 
hypertension among Medicare patients in all regions, two regions were analyzed as having 
higher rates of reimbursement and more appropriate LOS.  
 The correlation between the dependent variable LOS and the independent variable rate of 
reimbursement remained consistent even after the covariates were applied during a two-way test 
and a multiple regression analysis.  Alleviating variations in reimbursements may not be a quick 
process; however, applying uniform policies across the United States may assist in a more 
strategic form of reimbursements.  Lastly, the results of the research study may promote social 
change through the application of equivalent charges, reimbursements, and LOS across all four 
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